Mitophagy in carcinogenesis and cancer treatment
In order to maintain a functional mitochondrial network, cells have developed a quality control mechanism, namely mitophagy. This process can be induced through different pathways. The most studied is the so-called PINK1/Parkin pathway, which is associated with ubiquitylation of several mitochondria...
Saved in:
Published in | Discover. Oncology Vol. 12; no. 1; p. 58 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.12.2021
Springer Nature B.V Springer |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In order to maintain a functional mitochondrial network, cells have developed a quality control mechanism, namely mitophagy. This process can be induced through different pathways. The most studied is the so-called PINK1/Parkin pathway, which is associated with ubiquitylation of several mitochondrial proteins that were initially found to be related to Parkinson’s disease. Another type of mitophagy is known as receptor-mediated mitophagy, which includes proteins, such as BNIP3 and BNIP3L, also known as Nix. Through these two mechanisms, mitophagy fulfills its functions and maintains cellular homeostasis. Here, we summarize the current knowledge about the mechanisms of mitophagy regulation and their interplay with cancer progression as well as anticancer treatment. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 2730-6011 2730-6011 |
DOI: | 10.1007/s12672-021-00454-1 |